Radical prostatectomy versus high-dose irradiation in localized/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes
- 2 November 2014
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 54 (6) , 875-881
Abstract
Background. Treatment of localized prostate cancer (PC) is controversial. This is the first randomized study comparing an open surgery procedure (radical prostatectomy) with a combination of high-dose rate brachytherapy (2 × 10 Gy) and external beam radiotherapy (25 × 2 Gy) in PC patients in Sweden 1996–2001. The two randomization arms were compared regarding differences in patients-reported outcomes, such as complications and health-related quality of life (HRQoL). Material and methods. The patients had localized/locally advanced PC, clinical category T1b–T3a, N0, M0 and PSA ≤ 50 ng/ml. All underwent total androgen blockade (six months). Self-reported HRQoL and symptoms including urinary, bowel, and sexual side effects were investigated prospectively before randomization and 12 and 24 months after randomization. A total of 89 patients were randomized and completed the EORTC QLQ C-33 and EORTC PR-25 questionnaires. Results. Over the study period, there were no discernible differences in HRQoL, or complications between the two groups. Emotional functioning, however, improved statistically significantly over time, whereas Social functioning decreased, and financial difficulties increased. No statistically significant differences in group-by-time interactions were found. The survival rate was 76%. Only eight patients (9%) died of PC. Conclusion. Open radical prostatectomy and the combined high-dose rate brachytherapy with external beam radiation appeared to be comparable in the measured outcomes. It was not possible to draw any conclusion on the efficacy of the two treatments due to insufficient power of the study.Keywords
This publication has 14 references indexed in Scilit:
- Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupBJU International, 2012
- Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cellsEuropean Journal of Cancer, 2010
- Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?Cancer, 2009
- A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinomaCancer Treatment Reviews, 2009
- Radical prostatectomy versus high‐dose rate brachytherapy for prostate cancer: effects on health‐related quality of lifeBJU International, 2005
- Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer: A prospective assessment of acute and late treatment toxicityActa Oncologica, 2005
- Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with 192ir brachytherapy: A prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Laparoscopic Obturator Lymph Node Dissection in Patients with Prostatic CancerScandinavian Journal of Urology and Nephrology, 1995
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Radical Prostatectomy and Cystoprostatectomy with Preservation of Potency. Results Using a New Nerve‐sparing TechniqueBritish Journal of Urology, 1984